TP53-话题@MedSci

#TP53#

38篇内容 | 3320人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1458457, encodeId=3389145845e50, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=Nat Cancer：化疗和错配修复缺陷协同促进TP53突变的发生和急性淋巴细胞白血病的复发, objectType=article, longId=214726, objectId=0cd1214e26c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cd1214e26c8, replyNumber=0, likeNumber=120, createdTime=2021-07-25, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cd1214e26c8, moduleTitle=Nat Cancer：化疗和错配修复缺陷协同促进TP53突变的发生和急性淋巴细胞白血病的复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cd1214e26c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458456, encodeId=4dbb14584568a, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=Leukemia：iFCG化疗方案治疗携带IGHV突变且无TP53突变的慢性淋巴细胞白血病, objectType=article, longId=212646, objectId=63c52126468a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63c52126468a, replyNumber=0, likeNumber=145, createdTime=2021-06-13, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63c52126468a, moduleTitle=Leukemia：iFCG化疗方案治疗携带IGHV突变且无TP53突变的慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63c52126468a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458455, encodeId=cb4014584557c, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=Br J Cancer：TP53突变增加横纹肌肉瘤和尤文肉瘤的放疗抗性, objectType=article, longId=212076, objectId=595a2120e61c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=595a2120e61c, replyNumber=0, likeNumber=148, createdTime=2021-06-01, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=595a2120e61c, moduleTitle=Br J Cancer：TP53突变增加横纹肌肉瘤和尤文肉瘤的放疗抗性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=595a2120e61c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458454, encodeId=e35d145845445, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS和AML, objectType=article, longId=207335, objectId=402b20e335fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=402b20e335fd, replyNumber=0, likeNumber=108, createdTime=2021-02-21, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=402b20e335fd, moduleTitle=J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS和AML, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=402b20e335fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458453, encodeId=4e1f145845315, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS, objectType=article, longId=206018, objectId=3311206018ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3311206018ec, replyNumber=0, likeNumber=119, createdTime=2021-01-23, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3311206018ec, moduleTitle=J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3311206018ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458452, encodeId=e58b145845261, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=TP53突变型骨髓增生异常综合症：Eprenetapopt未达到III期研究的主要终点, objectType=article, longId=205306, objectId=719320530679, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=719320530679, replyNumber=0, likeNumber=100, createdTime=2021-01-06, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=719320530679, moduleTitle=TP53突变型骨髓增生异常综合症：Eprenetapopt未达到III期研究的主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=719320530679)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458451, encodeId=936d1458451b1, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=Aprea的Eprenetapopt尚未达到治疗TP53突变性骨髓增生异常综合症的主要终点, objectType=article, longId=204980, objectId=817f204980c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=817f204980c0, replyNumber=0, likeNumber=100, createdTime=2020-12-31, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=817f204980c0, moduleTitle=Aprea的Eprenetapopt尚未达到治疗TP53突变性骨髓增生异常综合症的主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=817f204980c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458450, encodeId=cda21458450b6, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=Prostate Cancer P D：中国人口中激素敏感性前列腺癌患者的TP53变异情况, objectType=article, longId=204058, objectId=387b20405844, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=387b20405844, replyNumber=0, likeNumber=93, createdTime=2020-12-04, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=387b20405844, moduleTitle=Prostate Cancer P D：中国人口中激素敏感性前列腺癌患者的TP53变异情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=387b20405844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458449, encodeId=2ba214584495c, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=Br J Cancer：突变型TP53与BCAR1相互作用促进癌细胞的侵袭, objectType=article, longId=203365, objectId=9242203365e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9242203365e7, replyNumber=0, likeNumber=105, createdTime=2020-11-15, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9242203365e7, moduleTitle=Br J Cancer：突变型TP53与BCAR1相互作用促进癌细胞的侵袭, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9242203365e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458448, encodeId=e6bb145844875, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=Clin Cancer Res：WEE1激酶抑制剂adavosertib联合化疗治疗TP53突变型卵巢癌, objectType=article, longId=199405, objectId=b6411994055d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6411994055d, replyNumber=0, likeNumber=79, createdTime=2020-08-15, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6411994055d, moduleTitle=Clin Cancer Res：WEE1激酶抑制剂adavosertib联合化疗治疗TP53突变型卵巢癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6411994055d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458447, encodeId=3494145844eec, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=Blood：TP53突变对MDS和继发性AML预后的影响, objectType=article, longId=198979, objectId=d15f1989e9c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d15f1989e9c9, replyNumber=0, likeNumber=93, createdTime=2020-08-09, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d15f1989e9c9, moduleTitle=Blood：TP53突变对MDS和继发性AML预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d15f1989e9c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458446, encodeId=90c514584466e, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=Oncogene：肿瘤抑制因子Tp53的缺失能够增强雄激素受体接到的致瘤转化和肿瘤发展, objectType=article, longId=178144, objectId=ea011e814495, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea011e814495, replyNumber=0, likeNumber=75, createdTime=2019-08-25, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea011e814495, moduleTitle=Oncogene：肿瘤抑制因子Tp53的缺失能够增强雄激素受体接到的致瘤转化和肿瘤发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea011e814495)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458445, encodeId=6baa1458445d3, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=Sci Rep：非肌肉浸润膀胱癌的基因表达分析阐释了Tp53状态和可变剪切本的作用, objectType=article, longId=176293, objectId=81421e629372, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81421e629372, replyNumber=0, likeNumber=99, createdTime=2019-07-29, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81421e629372, moduleTitle=Sci Rep：非肌肉浸润膀胱癌的基因表达分析阐释了Tp53状态和可变剪切本的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81421e629372)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458444, encodeId=86281458444c1, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=PLoS One：转移性前列腺恶性肿瘤中的TP53变异分析, objectType=article, longId=175035, objectId=796d1e50356b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=796d1e50356b, replyNumber=0, likeNumber=93, createdTime=2019-07-09, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=796d1e50356b, moduleTitle=PLoS One：转移性前列腺恶性肿瘤中的TP53变异分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=796d1e50356b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458443, encodeId=da7c1458443f6, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=BMC Cancer：TP53和XRCC1之间的相互作用增加了对宫颈癌发展的易感性, objectType=article, longId=157988, objectId=47e715e98856, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47e715e98856, replyNumber=0, likeNumber=66, createdTime=2019-01-15, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47e715e98856, moduleTitle=BMC Cancer：TP53和XRCC1之间的相互作用增加了对宫颈癌发展的易感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47e715e98856)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458442, encodeId=68db145844221, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=CLIN CANCER RES：针对卵巢癌TP53“热点突变”及特异性新抗原的T细胞反应, objectType=article, longId=154102, objectId=2da81541024c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2da81541024c, replyNumber=0, likeNumber=86, createdTime=2018-11-23, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2da81541024c, moduleTitle=CLIN CANCER RES：针对卵巢癌TP53“热点突变”及特异性新抗原的T细胞反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2da81541024c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458441, encodeId=a03814584417b, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=Blood：多发性骨髓瘤亚克隆的TP53拷贝数可独立指示患者预后, objectType=article, longId=152682, objectId=cfc715268280, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfc715268280, replyNumber=0, likeNumber=84, createdTime=2018-11-04, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfc715268280, moduleTitle=Blood：多发性骨髓瘤亚克隆的TP53拷贝数可独立指示患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfc715268280)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458440, encodeId=eef2145844005, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=Sci Rep：在前列腺癌细胞中，突变等位基因的定量研究阐释了TP53促使去势抵抗性的遗传基础, objectType=article, longId=148051, objectId=b49714805154, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b49714805154, replyNumber=0, likeNumber=83, createdTime=2018-09-04, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b49714805154, moduleTitle=Sci Rep：在前列腺癌细胞中，突变等位基因的定量研究阐释了TP53促使去势抵抗性的遗传基础, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b49714805154)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458439, encodeId=0cd2145843929, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=Gastroenterology：TP53是巴雷特食管患者高级别进展的重要预测因素, objectType=article, longId=134157, objectId=f50813415ea6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f50813415ea6, replyNumber=0, likeNumber=80, createdTime=2018-04-05, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f50813415ea6, moduleTitle=Gastroenterology：TP53是巴雷特食管患者高级别进展的重要预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f50813415ea6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458438, encodeId=963e1458438bd, content=<a href='/topic/show?id=50a81e6869e' target=_blank style='color:#2F92EE;'>#TP53#</a>, objectTitle=JCO：TP53胚系突变与儿童急性淋巴细胞白血病的易感性和预后的关系, objectType=article, longId=126478, objectId=4bd21264e81e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bd21264e81e, replyNumber=0, likeNumber=91, createdTime=2018-01-15, rootId=0, userName=zblhy, userId=2d276073420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bd21264e81e, moduleTitle=JCO：TP53胚系突变与儿童急性淋巴细胞白血病的易感性和预后的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bd21264e81e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

TP53

2020-05-29

zblhy

#TP53#

Nat Cancer：化疗和错配修复缺陷协同促进TP53突变的发生和急性淋巴细胞白血病的复发

2021-07-25

zblhy

#TP53#

Leukemia：iFCG化疗方案治疗携带IGHV突变且无TP53突变的慢性淋巴细胞白血病

2021-06-13

zblhy

#TP53#

Br J Cancer：TP53突变增加横纹肌肉瘤和尤文肉瘤的放疗抗性

2021-06-01

zblhy

#TP53#

J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS和AML

2021-02-21

zblhy

#TP53#

J Clin Oncol：Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS

2021-01-23

zblhy

#TP53#

TP53突变型骨髓增生异常综合症：Eprenetapopt未达到III期研究的主要终点

2021-01-06

医者仁心

#TP53#

Aprea的Eprenetapopt尚未达到治疗TP53突变性骨髓增生异常综合症的主要终点

2020-12-31

zblhy

#TP53#

Prostate Cancer P D：中国人口中激素敏感性前列腺癌患者的TP53变异情况

2020-12-04

zblhy

#TP53#

Br J Cancer：突变型TP53与BCAR1相互作用促进癌细胞的侵袭

2020-11-15

zblhy

#TP53#

Clin Cancer Res：WEE1激酶抑制剂adavosertib联合化疗治疗TP53突变型卵巢癌

2020-08-15

zblhy

#TP53#

Blood：TP53突变对MDS和继发性AML预后的影响

2020-08-09

zblhy

#TP53#

Oncogene：肿瘤抑制因子Tp53的缺失能够增强雄激素受体接到的致瘤转化和肿瘤发展

2019-08-25

zblhy

#TP53#

Sci Rep：非肌肉浸润膀胱癌的基因表达分析阐释了Tp53状态和可变剪切本的作用

2019-07-29

zblhy

#TP53#

PLoS One：转移性前列腺恶性肿瘤中的TP53变异分析

2019-07-09

zblhy

#TP53#

BMC Cancer：TP53和XRCC1之间的相互作用增加了对宫颈癌发展的易感性

2019-01-15

zblhy

#TP53#

CLIN CANCER RES：针对卵巢癌TP53“热点突变”及特异性新抗原的T细胞反应

2018-11-23

zblhy

#TP53#

Blood：多发性骨髓瘤亚克隆的TP53拷贝数可独立指示患者预后

2018-11-04

zblhy

#TP53#

Sci Rep：在前列腺癌细胞中，突变等位基因的定量研究阐释了TP53促使去势抵抗性的遗传基础

2018-09-04

zblhy

#TP53#

Gastroenterology：TP53是巴雷特食管患者高级别进展的重要预测因素

2018-04-05

zblhy

#TP53#

JCO：TP53胚系突变与儿童急性淋巴细胞白血病的易感性和预后的关系

2018-01-15